Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/4/2020
SIETES contiene 92957 citas

 
 
<< anterior 21 a 40 de 713 siguiente >>
Presentar resultados
Seleccionar todas
24.Tiene citas relacionadas
25. Cita con resumen
Sherer R. Generic antiretrovirals and the uncertain future of HIV care in the United States. Ann Intern Med 2013;158:133-4. [Ref.ID 94776]
26. Cita con resumen
Anónimo. A 4-drug combination (Stribild) for HIV. Med Lett Drugs Ther 2012;54:95-6. [Ref.ID 94145]
28.Tiene citas relacionadas Cita con resumen
Wu C-Y, Chen Y-J, Ho HJ, Hsu Y-C, Kup KN, Wu M-S, Lin J-T. Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA 2012;308:1906-13. [Ref.ID 94062]
29. Cita con resumen
Aldea A, García Sánchez-Colomer M, Fernández Quintana E, García Sáiz M. Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009. Eur J Clin Pharmacol 2012;68:1329-38. [Ref.ID 93650]
30. Cita con resumen
Violari A, Lindsey JC, Hughes MD, Mujuru HA, Barlow-Mosha L, Kamthunzi P, Chi BH, Cotton MF, Moultrie H, Khadse S, Schimana W, Bobat R, Purdue L, Eshleman SH, Abrams EJ, Millar L, Petzold E, Mofenson LM, Hean-Philippe P, Palumbo P. Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children. N Engl J Med 2012;366:2380-9. [Ref.ID 93319]
31.
Daar ES, Tierney C, Fischl MA, Sax PE, Mollan K, Budhathoki C, Godfrey C, Jahed NC, Myers LK, Katzenstein D, Farajallah A, Rooney JF, Pappa KA, Woodward WC, Patterson K, Bolivar H, Benson CA, Collier AC, for the AIDS Clinical Trials Group Study A5202 Team. Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1. A randomized trial. Ann Intern Med 2011;154:445-56. [Ref.ID 91259]
32. Cita con resumen
Anónimo. FDA approves once-daily combination or treatment-naive HIV patients.. DIA Daily 2011:11 agosto. [Ref.ID 91191]
33.Enlace a cita originalTiene citas relacionadas
Chaponda M, Pirmohamed M. Hypersensitivity reactions to HIV therapy. Br J Clin Pharmacol 2011;71:659-71. [Ref.ID 90599]
35. Cita con resumen
Stevens AJ, Jensen JJ, Wyller K, Kilgore PC, Chatterjee S, Rohrbaugh ML. The role of public-sector research in the discovery of drugs and vaccines. N Engl J Med 2011;364:535-41. [Ref.ID 90172]
36. Cita con resumen
Reuben A, Koch DG, Lee WM, Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010;52:2065-76. [Ref.ID 89970]
37. Cita con resumen
Hughes R. Investigation of peripheral neuropathy. BMJ 2010;341:1161-2. [Ref.ID 89724]
38.Tiene citas relacionadas
Lallemant M, Jourdain G. Preventing mother-to-child transmission of HIV - Protecting this generation and the next. N Engl J Med 2010;363:1570-2. [Ref.ID 89500]
39.Tiene citas relacionadas
Palumbo P, Lindsey JC, Hughes MD, Cotton MF, Bobat R, Meyers T, Bwakura-Dangarembizi M, Chi BH, Musoke P, Kamthunzi P, Shimana W, Purdue L, Eshleman SH, Abrams EJ, Millar L, Petzold E, Mofenson LM, Jean-Philippe P, Violari A. Antiretroviral treatment for children with peripartum nevirapine exposure. N Engl J Med 2010;363:1510-20. [Ref.ID 89498]
40.Tiene citas relacionadas
Lockman S, McIntyre HJ, Zheng Y, Chipato T, Conradie F, Sawe F, Asmelash SA, Hosseinipour MC, Mohapi L, Stringer E, Mngqibisa R, Siika A, Atwine D, Hakim J, Shaffer D, Kanyama C, Wools-Kaloustian K, Salata RA, Hogg E, Alston-Smith B, Walawander A, Purcelle-Smith E, Eshleman S, Rooney J, Rahim S, Mellors JW, Schooley RT, Currier JS, for the OCTANE A5208 Study Team. Antiretroviral therapies in women after single-dose nevirapine exposure. N Engl J Med 2010;363:1499-509. [Ref.ID 89497]
Seleccionar todas
 
<< anterior 21 a 40 de 713 siguiente >>